{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:39:27Z","timestamp":1788431967866,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jgo.2022.10.002","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T03:07:08Z","timestamp":1666235228000},"page":"101387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review"],"prefix":"10.1016","volume":"14","author":[{"given":"Penny","family":"Mackenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Vajdic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Comans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Agar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2022.10.002_bb0005","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ijc.33232","article-title":"Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050","volume":"148","author":"Pilleron","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jgo.2022.10.002_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tipsro.2020.09.003","article-title":"Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia","volume":"16","author":"Mackenzie","year":"2020","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"issue":"17","key":"10.1016\/j.jgo.2022.10.002_bb0015","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1200\/JCO.2012.41.6727","article-title":"Under-representation of older adults in cancer registration trials: known problem, little progress","volume":"30","author":"Scher","year":"2012","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jgo.2022.10.002_bb0020","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1056\/NEJMp2106089","article-title":"Treatment of older adults with cancer\u2014addressing gaps in evidence","volume":"385","author":"Bertagnolli","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jgo.2022.10.002_bb0025","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1093\/annonc\/mdu104","article-title":"Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force","volume":"25","author":"Kunkler","year":"2014","journal-title":"Ann Oncol"},{"issue":"19","key":"10.1016\/j.jgo.2022.10.002_bb0030","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jgo.2022.10.002_bb0035","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-course radiation plus temozolomide in elderly patients with glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jgo.2022.10.002_bb0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial","volume":"16","author":"Kunkler","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2022.10.002_bb0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jebm.12141","article-title":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review","volume":"8","author":"Zeng","year":"2015","journal-title":"J Evid Based Med"},{"key":"10.1016\/j.jgo.2022.10.002_bb0050","author":"Wells"},{"issue":"4","key":"10.1016\/j.jgo.2022.10.002_bb0055","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1245\/s10434-012-2693-8","article-title":"Factors influencing surgical and adjuvant therapy in stage I breast cancer: a SEER 18 database analysis","volume":"20","author":"Showalter","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1306","key":"10.1016\/j.jgo.2022.10.002_bb0060","article-title":"Radiotherapy utilisation in lung cancer in New Zealand: disparities with optimal rates explained","volume":"122","author":"Stevens","year":"2009","journal-title":"N Z Med J (Online)"},{"issue":"35","key":"10.1016\/j.jgo.2022.10.002_bb0065","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1200\/JCO.2010.30.0731","article-title":"Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis","volume":"28","author":"Palma","year":"2010","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.jgo.2022.10.002_bb0070","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/pros.23496","article-title":"National trends in management of localized prostate cancer: a population based analysis 2004-2013","volume":"78","author":"Chen","year":"2018","journal-title":"Prostate"},{"issue":"19","key":"10.1016\/j.jgo.2022.10.002_bb0075","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/cncr.28856","article-title":"Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic features","volume":"120","author":"Kalbasi","year":"2014","journal-title":"Cancer."},{"issue":"3","key":"10.1016\/j.jgo.2022.10.002_bb0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejca.2010.03.015","article-title":"Socioeconomic inequalities in the use of radiotherapy for rectal cancer: a nationwide study","volume":"47","author":"Olsson","year":"2011","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.jgo.2022.10.002_bb0085","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.wneu.2011.12.008","article-title":"Survival and treatment patterns of glioblastoma in the elderly: a population-based study","volume":"78","author":"Gulati","year":"2012","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.jgo.2022.10.002_bb0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijrobp.2010.04.033","article-title":"Effectiveness of radiotherapy for elderly patients with glioblastoma","volume":"81","author":"Scott","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"14","key":"10.1016\/j.jgo.2022.10.002_bb0095","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1002\/cncr.26589","article-title":"Patterns of care and treatment outcomes for elderly women with cervical cancer","volume":"118","author":"Sharma","year":"2012","journal-title":"Cancer."},{"issue":"2","key":"10.1016\/j.jgo.2022.10.002_bb0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0360-3016(00)00440-5","article-title":"Association between age and the utilization of radiotherapy in Ontario","volume":"47","author":"Tyldesley","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.jgo.2022.10.002_bb0105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/COC.0000000000000309","article-title":"Utilization of postoperative chemoradiotherapy among women in the United States with high-risk cervical Cancer","volume":"41","author":"Trifiletti","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2022.10.002_bb0110","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/cncr.27802","article-title":"A population-based study of metastatic colorectal cancer in individuals aged\u2265 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer","volume":"119","author":"Kumar","year":"2013","journal-title":"Cancer."},{"issue":"3","key":"10.1016\/j.jgo.2022.10.002_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2019.01.002","article-title":"A population-based study of palliative radiation therapy for bone metastases in patients dying of prostate cancer","volume":"9","author":"Cho","year":"2019","journal-title":"Pract Radiat Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2022.10.002_bb0120","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.3892\/ol.2016.5003","article-title":"Impact of intense systemic therapy and improved survival on the use of palliative radiotherapy in patients with bone metastases from prostate cancer","volume":"12","author":"Nieder","year":"2016","journal-title":"Oncol Lett"},{"issue":"6","key":"10.1016\/j.jgo.2022.10.002_bb0125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/pros.23294","article-title":"Local therapy improves overall survival in patients with newly diagnosed metastatic prostate cancer","volume":"77","author":"Parikh","year":"2017","journal-title":"Prostate"},{"issue":"9","key":"10.1016\/j.jgo.2022.10.002_bb0130","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1080\/0284186X.2018.1468087","article-title":"Factors influencing access to palliative radiotherapy: a Norwegian population-based study","volume":"57","author":"\u00c5sli","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jgo.2022.10.002_bb0135","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s12094-020-02355-1","article-title":"A population perspective on the use of external beam radiotherapy in Catalonia","volume":"22","author":"Corral","year":"2020","journal-title":"Spain Clin Transl Oncol"},{"issue":"10","key":"10.1016\/j.jgo.2022.10.002_bb0140","first-page":"3059","article-title":"Variations in intensity of end-of-life cancer therapy by cancer type at a Canadian tertiary cancer centre between 2003 and 2010","volume":"23","author":"Grendarova","year":"2015","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.jgo.2022.10.002_bb0145","doi-asserted-by":"crossref","DOI":"10.1200\/JOP.2012.000835","article-title":"Patterns of care in palliative radiotherapy: a population-based study","volume":"9","author":"Murphy","year":"2013","journal-title":"J Oncol Pract"},{"issue":"4","key":"10.1016\/j.jgo.2022.10.002_bb0150","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/cncr.20443","article-title":"Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence","volume":"101","author":"Delaney","year":"2004","journal-title":"Cancer."},{"issue":"3","key":"10.1016\/j.jgo.2022.10.002_bb0155","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/cncr.20789","article-title":"Estimating the optimal external-beam radiotherapy utilization rate for genitourinary malignancies","volume":"103","author":"Delaney","year":"2005","journal-title":"Cancer."},{"issue":"9","key":"10.1016\/j.jgo.2022.10.002_bb0160","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/cncr.11740","article-title":"Estimation of an optimal radiotherapy utilization rate for breast carcinoma","volume":"98","author":"Delaney","year":"2003","journal-title":"Cancer."},{"issue":"5","key":"10.1016\/j.jgo.2022.10.002_bb0165","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.ijrobp.2009.12.070","article-title":"Estimating the need for radiotherapy for patients with prostate, breast, and lung cancers: verification of model estimates of need with radiotherapy utilization data from British Columbia","volume":"79","author":"Tyldesley","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.jgo.2022.10.002_bb0170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S1470-2045(03)00984-7","article-title":"A model for decision making for the use of radiotherapy in lung cancer","volume":"4","author":"Delaney","year":"2003","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.jgo.2022.10.002_bb0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/cncr.21596","article-title":"Estimating the optimal radiotherapy utilization for carcinoma of the central nervous system, thyroid carcinoma, and carcinoma of unknown primary origin from evidence-based clinical guidelines","volume":"106","author":"Delaney","year":"2006","journal-title":"Cancer: Interdisc Int J Am Cancer Soc"},{"issue":"4","key":"10.1016\/j.jgo.2022.10.002_bb0180","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/cncr.20444","article-title":"Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: Part I\u2013Malignancies of the cervix, ovary, vagina, and vulva","volume":"101","author":"Delaney","year":"2004","journal-title":"Cancer."},{"issue":"S7","key":"10.1016\/j.jgo.2022.10.002_bb0185","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/1097-0142(19941001)74:7+<2107::AID-CNCR2820741719>3.0.CO;2-1","article-title":"Clinical aspects of cancer in the elderly. Treatment decisions, treatment choices, and follow-up","volume":"74","author":"McKenna","year":"1994","journal-title":"Cancer."},{"key":"10.1016\/j.jgo.2022.10.002_bb0190","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(20)30741-5","article-title":"Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)","volume":"22","author":"Biganzoli","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2022.10.002_bb0195","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejca.2019.04.031","article-title":"Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients","volume":"116","author":"Boyle","year":"2019","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.jgo.2022.10.002_bb0200","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.ejso.2018.08.003","volume":"44","author":"Montroni","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.jgo.2022.10.002_bb0205","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMra1608986","article-title":"Recent developments in radiotherapy","volume":"377","author":"Citrin","year":"2017","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jgo.2022.10.002_bb0210","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2022.10.002_bb0215","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.jgo.2022.10.002_bb0220","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/annonc\/mds081","article-title":"Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands","volume":"23","author":"Haasbeek","year":"2012","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.jgo.2022.10.002_bb0225","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/85.9.704","article-title":"Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials","volume":"85","author":"Curran","year":"1993","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.jgo.2022.10.002_bb0230","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7765","article-title":"Individual and population comparisons of surgery and radiotherapy outcomes in prostate Cancer using Bayesian multistate models","volume":"2","author":"Beesley","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"9077","key":"10.1016\/j.jgo.2022.10.002_bb0235","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","article-title":"Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer","volume":"350","author":"Landoni","year":"1997","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.jgo.2022.10.002_bb0240","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa065901","article-title":"Radiotherapy for glioblastoma in the elderly","volume":"356","author":"Keime-Guibert","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jgo.2022.10.002_bb0245","first-page":"225","article-title":"Predictors of referral for adjuvant therapy for colorectal cancer","volume":"48","author":"Ong","year":"2005","journal-title":"Can J Surg"},{"issue":"6","key":"10.1016\/j.jgo.2022.10.002_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cllc.2016.05.012","article-title":"Assessment of referral and chemotherapy treatment patterns for elderly patients with non\u2013small-cell lung cancer","volume":"17","author":"Dawe","year":"2016","journal-title":"Clin Lung Cancer"},{"issue":"11","key":"10.1016\/j.jgo.2022.10.002_bb0255","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2022.10.002_bb0260","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"issue":"31","key":"10.1016\/j.jgo.2022.10.002_bb0265","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: trans-Tasman Radiation Oncology Group trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2022.10.002_bb0270","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1754-9485.2011.02292.x","article-title":"A decade of investment in radiotherapy in New South Wales: why does the gap between optimal and actual persist?","volume":"55","author":"Barton","year":"2011","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2022.10.002_bb0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2007.03.006","article-title":"An evidence-based estimation of local control and survival benefit of radiotherapy for breast cancer","volume":"84","author":"Shafiq","year":"2007","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2022.10.002_bb0280","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clon.2009.11.003","article-title":"Estimation of an optimal utilisation rate for palliative radiotherapy in newly diagnosed cancer patients","volume":"22","author":"Jacob","year":"2010","journal-title":"Clin Oncol"},{"issue":"10","key":"10.1016\/j.jgo.2022.10.002_bb0285","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.clon.2016.05.006","article-title":"A population-based model of local control and survival benefit of radiotherapy for lung cancer","volume":"28","author":"Shafiq","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406822002363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406822002363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:57:48Z","timestamp":1761818268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406822002363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1879406822002363"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2022.10.002","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2022.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101387"}}